Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

Completed

Conditions studied: Multiple Sclerosis

In brief

The purpose of this follow-up study is to look carefully at the long-term course of multiple sclerosis (MS) and possibly the long-term effects of Betaseron in the patients who were previously enrolled in the original North American study that led to the marketing approval of Betaseron.

Key facts

Study ID

NCT00206635

Run by

Bayer

People needed

432

Starts

2005-01-01

Expected to finish

2005-12-01

Last updated by the study team

2012-11-22

Who can join

Age: 33 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients in North America have to have been previously enrolled in the original Betaseron trial from 1988-1993
• Be able to understand the consent form (or have a guardian who can)

You may not qualify if…

• North American patients cannot be included if they have not participated in the original Betaseron trial from 1988-1993

Where it is running

• Study site — Many Locations, Alabama, United States
• Study site — Many Locations, Arizona, United States
• Study site — Many Locations, California, United States
• Study site — Many Locations, Illinois, United States
• Study site — Many Locations, Maryland, United States
• Study site — Many Locations, Pennsylvania, United States
• Study site — Many Locations, British Columbia, Canada
• Study site — Many Locations, Ontario, Canada
• Study site — Many Locations, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.